Condition

PAD clinical trials and research

As of November 12, 2026, Find a Trial lists 3 PAD clinical trials that are recruiting, at sites in 3 countries (most in Taiwan (1), Germany (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest PAD clinical trials

StudyPhaseWhereStatusRegistered
Breaking up arterial calcification with intravascular lithotripsy to improve blood flow in people with PAD — Essen, North Rhine-Westphalia and 1 other locations Recruiting Aug 19, 2025
Testing the Thor system for treating blocked leg arteries — St. Helena, California and 28 other locations Recruiting Jun 23, 2023
Using bamboo charcoal and probiotics to improve kidney and vascular health in patients with chronic kidney disease and peripheral artery disease — Taipei, Taiwan Recruiting Mar 9, 2021

All recruiting trials (3)

Related topics

CKDPAD - Peripheral Arterial DiseasePeripheral Artery Disease

Quick answers

How many PAD clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Taiwan (1 trial), Germany (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.